| Scrip Code | 543220 |
|---|---|
| NSE Symbol | MAXHEALTH |
| MSEI Symbol | NOTLISTED |
| ISIN | INE027H01010 |
| Name of company | Max Healthcare Institute Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 21-05-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 15-05-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Fourth quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Single segment |
| Description of single segment | Medical and Healthcare Services |
| Start date and time of board meeting | 21-05-2026 12:07:00 |
| End date and time of board meeting | 21-05-2026 15:44:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 2,14,289.00 | 8,37,345.00 | |
| Other income | 4,783.00 | 16,262.00 | |
| Total income | 2,19,072.00 | 8,53,607.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 43,331.00 | 1,79,875.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 623.00 | (873.00) |
| (d) | Employee benefit expense | 34,027.00 | 1,35,712.00 |
| (e) | Finance costs | 6,666.00 | 23,510.00 |
| (f) | Depreciation, depletion and amortisation expense | 12,302.00 | 44,653.00 |
| (f) | Other Expenses | ||
| 1 | Professional and consultancy fees | 47,290.00 | 1,79,401.00 |
| 2 | Other Expenses | 28,375.00 | 1,18,947.00 |
| Total other expenses | 75,665.00 | 2,98,348.00 | |
| Total expenses | 1,72,614.00 | 6,81,225.00 | |
| 3 | Total profit before exceptional items and tax | 46,458.00 | 1,72,382.00 |
| 4 | Exceptional items | 0.00 | (4,824.00) |
| 5 | Total profit before tax | 46,458.00 | 1,67,558.00 |
| 6 | Tax expense | ||
| 7 | Current tax | 5,858.00 | 21,131.00 |
| 8 | Deferred tax | 6,378.00 | 2,186.00 |
| 9 | Total tax expenses | 12,236.00 | 23,317.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 34,222.00 | 1,44,241.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 34,222.00 | 1,44,241.00 |
| 17 | Other comprehensive income net of taxes | 125.00 | (158.00) |
| 18 | Total Comprehensive Income for the period | 34,347.00 | 1,44,083.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | |||
| Total profit or loss, attributable to non-controlling interests | |||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | |||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 97,313.00 | 97,313.00 | |
| Face value of equity share capital | 10 | 10 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 9,77,350.00 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 3.52 | 14.83 | |
| Diluted earnings (loss) per share from continuing operations | 3.5 | 14.76 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 3.52 | 14.83 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 3.5 | 14.76 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | For Notes, kindly refer PDF file of Financial Results available on stock exchanges website viz. www.bseindia.com & www.nseindia.com. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | ||
|---|---|---|---|
| Date of start of reporting period | 01-04-2025 | ||
| Date of end of reporting period | 31-03-2026 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 6,97,996.00 | ||
| Capital work-in-progress | 59,224.00 | ||
| Investment property | 466.00 | ||
| Goodwill | 3,48,824.00 | ||
| Other intangible assets | 2,51,820.00 | ||
| Intangible assets under development | 81.00 | ||
| Biological assets other than bearer plants | 0.00 | ||
| Investments accounted for using equity method | 0.00 | ||
| Non-current financial assets | |||
| Non-current investments | 546.00 | ||
| Trade receivables, non-current | 7,915.00 | ||
| Loans, non-current | 74,645.00 | ||
| Other non-current financial assets | |||
| 1 | Other financial assets | 20,391.00 | |
| Total of other non-current financial assets | 20,391.00 | ||
| Total non-current financial assets | 1,03,497.00 | ||
| Deferred tax assets (net) | 4,649.00 | ||
| Other non-current assets | |||
| 1 | Income tax assets (net) | 26,405.00 | |
| 2 | Other non-current assets | 35,653.00 | |
| Total of other non-current assets | 62,058.00 | ||
| Total non-current assets | 15,28,615.00 | ||
| 2 | Current assets | ||
| Inventories | 11,428.00 | ||
| Current financial asset | |||
| Current investments | 0.00 | ||
| Trade receivables, current | 96,975.00 | ||
| Cash and cash equivalents | 66,580.00 | ||
| Bank balance other than cash and cash equivalents | 3,480.00 | ||
| Loans, current | 0.00 | ||
| Other current financial assets | |||
| Total of other current financial assets | 7,057.00 | ||
| Total current financial assets | 1,74,092.00 | ||
| Current tax assets (net) | 3,480.00 | ||
| Other current assets | |||
| 1 | Other current assets | 5,479.00 | |
| Total of other current assets | 5,479.00 | ||
| Total current assets | 1,94,479.00 | ||
| 3 | Non-current assets classified as held for sale | ||
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | ||
| Total assets | 17,23,094.00 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 97,313.00 | ||
| Other equity | 9,77,350.00 | ||
| Total equity attributable to owners of parent | 10,74,663.00 | ||
| Non controlling interest | 0.00 | ||
| Total equity | 10,74,663.00 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 2,97,798.00 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | ||
| Total Trade payable | 0.00 | ||
| Other non-current financial liabilities | |||
| 1 | Other financial liabilities | 26,857.00 | |
| Total of other non-current financial liabilities | 26,857.00 | ||
| Total non-current financial liabilities | 3,24,655.00 | ||
| Provisions, non-current | 12,782.00 | ||
| Deferred tax liabilities (net) | 68,753.00 | ||
| Deferred government grants, Non-current | 0.00 | ||
| Other non-current liabilities | |||
| 1 | Other non-current liabilities | 23,547.00 | |
| Total of other non-current liabilities | 23,547.00 | ||
| Total non-current liabilities | 4,29,737.00 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 50,038.00 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 1,260.00 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 84,644.00 | ||
| Total Trade payable | 85,904.00 | ||
| Other current financial liabilities | |||
| 1 | Other financial liabilities | 57,253.00 | |
| Total of other current financial liabilities | 57,253.00 | ||
| Total current financial liabilities | 1,93,195.00 | ||
| Other current liabilities | 17,356.00 | ||
| 1 | Other current liabilities | 17,356.00 | |
| Total of other current liabilities | 17,356.00 | ||
| Provisions, current | 8,143.00 | ||
| Current tax liabilities (Net) | 0.00 | ||
| Deferred government grants, Current | 0.00 | ||
| Total current liabilities | 2,18,694.00 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 | |
| Total liabilities | 6,48,431.00 | ||
| Total equity and liabilites | 17,23,094.00 | ||
| Disclosure of notes on assets and liabilities | Textual Information(1) | ||
| Textual Information(1) | For notes, kindly refer PDF file of Financial Results available on stock exchanges website viz. www.bseindia.com & www.nseindia.com |
|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | |||||
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | |||||
| Whether results are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement gain/(loss) on defined benefit plans | 105.00 | (181.00) |
| Total Amount of items that will not be reclassified to profit and loss | 105.00 | (181.00) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 34.00 | 3.00 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Exchange differences on translation of foreign operations | 54.00 | 26.00 |
| Total Amount of items that will be reclassified to profit and loss | 54.00 | 26.00 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 125.00 | (158.00) |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 31-03-2026 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 1,67,558.00 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 21,504.00 | |||||
| Adjustments for decrease (increase) in inventories | (873.00) | |||||
| Adjustments for decrease (increase) in trade receivables, current | (32,312.00) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (2,379.00) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | (1,305.00) | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | 7,329.00 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 417.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 44,653.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 2,855.00 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 0.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | 266.00 | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 10,970.00 | |||||
| Adjustments for share-based payments | 4,833.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | (1,054.00) | |||||
| Other adjustments for non-cash items | 0.00 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 32,964.00 | |||||
| Net cash flows from (used in) operations | 2,00,522.00 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 37,190.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 1,63,332.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 128.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 385.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 1,605.00 | |||||
| Purchase of property, plant and equipment | 1,48,453.00 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 42,000.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 5,700.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 11,875.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 2,631.00 | |||||
| Net cash flows from (used in) investing activities | (1,68,899.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 3,382.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 56,774.00 | |||||
| Repayments of borrowings | 14,381.00 | |||||
| Payments of lease liabilities | 2,609.00 | |||||
| Dividends paid | 14,562.00 | |||||
| Interest paid | 22,677.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | 5,927.00 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 360.00 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 62.00 | |||||
| Net increase (decrease) in cash and cash equivalents | 422.00 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 66,158.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 66,580.00 | |||||
| Whether results are audited or unaudited | Audited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | M/s. S.R. Batliboi & Co. LLP, Chartered Accountants | Yes | 31-07-2027 | ||
|---|---|---|---|---|---|